The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis

by Stephen Patterson, Susan Wyllie, Suzanne Norval, Laste Stojanovski, Frederick RC Simeons, Jennifer L Auer, Maria Osuna-Cabello, Kevin D Read, Alan H Fairlamb
Published 2016-05-01